Axonics

Axonics Working Capital Turnover

Working Capital Turnover of Axonics (AXNX) as of Nov 19, 2026.

Working Capital Turnover

-

Last updated:

Working Capital Turnover of Axonics is 2026 - . Working Capital Turnover of Axonics was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Axonics Stock analysis

What does Axonics do? Axonics Modulation Technologies Inc. is a medical device company that was founded in 2013 and is headquartered in Irvine, California. The company specializes in the development and marketing of innovative therapy devices for the treatment of bladder dysfunction and bowel diseases. Axonics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Axonics stock

On Eulerpool you can find the complete historical development of Working Capital Turnover Axonics since 2006 – with annual values, charts, and detailed analysis.

Working capital turnover measures how efficiently a company uses its working capital to generate revenue. Higher ratios indicate more efficient short-term asset utilization.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Working Capital Turnover's Axonics with sector peers and the industry average to assess whether it is attractive.

To evaluate Working Capital Turnover's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Working Capital Turnover.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Axonics

All Key Metrics — Axonics